Researchers at the University of Texas Medical Branch have discovered how a key protein switch allows Chikungunya Virus (CHIKV) to spread to new vectors. The study, published December 7 in PLoS Pathogens, explains how the virus has increased its ability to infect and be transmitted by the Asian tiger mosquito, Aedes albopictus.
CHIKV is an emerging arbovirus associated with several recent large-scale epidemics of arthritic disease. The virus has formerly been known to be carried primarily by the mosquito Aedes aegypti. However, a recent epidemic in the Indian Ocean islands suggested that something else was carrying the virus, as Ae. aegypti are not found there. In fact the relative Asian tiger mosquito, Ae. albopictus, was present. This prompted the team, led by Dr. Stephen Higgs, to look further into the virus.
In an earlier study it had been found that the epidemics on islands in the Indian Ocean were associated with a strain of CHIKV with a mutation in the envelope protein gene (E1-A226V). Therefore, the researchers investigated the role of the E1-A226V mutation on the fitness of CHIKV in both types of mosquitoes. The team infected mosquitoes with two genetically-engineered clones of the virus, one with the mutation and the other without.
The team found the mutant virus out-competed the other virus with respect to transmission by the tiger mosquito. This proved that EI-A226V is directly responsible for CHIKV adaptation to the Asian tiger mosquito, explaining why the virus was found in an area which lacks the typical vector mosquito.
The Asian tiger mosquito is present in many countries. Both mosquito species are currently present in the U.S. and the Asian tiger mosquito is spreading in Europe. The findings suggest that, especially with the global climate warming, CHIKV could expand to new geographic locations.
CITATION: Tsetsarkin KA, Vanlandingham DL, McGee CE, Higgs S (2007) A single mutation in Chikungunya virus affects vector specificity and epidemic potential. PLoS Pathog 3(12): e201. doi:10.1371/journal.ppat.0030201
CONTACT:
Jim Kelly
University of Texas Medical Branch at Galveston
(409)-772-8791
(800)-228-1841
jpkelly@utmb.edu
Disclaimer
This press release refers to an upcoming article in PLoS Pathogens. The release is provided by journal staff. Any opinions expressed in these releases or articles are the personal views of the journal staff and/or article contributors, and do not necessarily represent the views or policies of PLoS. PLoS expressly disclaims any and all warranties and liability in connection with the information found in the releases and articles and your use of such information.
About PLoS Pathogens
PLoS Pathogens (www.plospathogens.org) publishes outstanding original articles that significantly advance the understanding of pathogens and how they interact with their host organisms. All works published in PLoS Pathogens are open access. Everything is immediately available subject only to the condition that the original authorship and source are properly attributed. Copyright is retained by the authors. The Public Library of Science uses the Creative Commons Attribution License.
About the Public Library of Science
The Public Library of Science (PLoS) is a non-profit organization of scientists and physicians committed to making the world's scientific and medical literature a freely available public resource. For more information, visit http://www.plos.org.
PLEASE MENTION THE OPEN-ACCESS JOURNAL PLoS PATHOGENS (www.plospathogens.org) AS THE SOURCE FOR THIS ARTICLE AND PROVIDE A LINK TO THE FREELY AVAILABLE TEXT. THANK YOU.
PLoS Pathogens is an open-access, peer-reviewed journal published weekly by the Public Library of Science (PLoS).
Journal
PLOS Pathogens